C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 403/12 (2006.01) A61K 31/55 (2006.01)
Patent
CA 2519515
The present invention is directed to compounds that are antagonists of CGRP receptors and that are useful in the treatment or prevention of diseases in which the CGRP is involved, such as headache, migraine and cluster headache. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved.
L'invention concerne des composés antagonistes des récepteurs de CGRP (peptide dérivé du gène de la calcitonine) utilisés pour traiter ou prévenir des maladies dans lesquelles CGRP est impliqué, telles que les céphalées, les migraines et les céphalées vasculaires de Horton. L'invention concerne également des compositions pharmaceutiques comprenant ces composés et l'utilisation de ces composés et compositions pour prévenir ou traiter des maladies dans lesquelles CGRP est impliqué.
Bell Ian M.
Graham Samuel L.
Stump Craig A.
Williams Theresa M.
Merck & Co. Inc.
Merck Sharp & Dohme Corp.
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
LandOfFree
Benodiazepine spirohydantoin cgrp receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benodiazepine spirohydantoin cgrp receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benodiazepine spirohydantoin cgrp receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1955804